E 115
Pill imprint E 115 has been identified as Ticlopidine HCl 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlopidine HCl Images
- Imprint:
-
E 115
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
povidone
titanium dioxide
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0115
Advertisement
More Ticlopidine HCl resources
- Ticlopidine (Wolters Kluwer)
- ticlopidine (Cerner Multum)
- ticlopidine (Micromedex) - Includes Dosage Information
- Ticlopidine Hydrochloride (AHFS DI)
- Ticlopidine (FDA)
- Ticlopidine Hydrochloride (Wolters Kluwer)
Search Again
